Technology CEVEC's innovative and proprietary technology uses human amniocytes to establish permanent cell lines (CAP cell lines) for production of biopharmaceuticals.

  


Using CEVEC's proprietary technology, primary human amniocytes have been immortalized by adenoviral genetic E1/pIX functions and selected for highly efficient CAP (CEVEC's Amniocyte Production) Cell Lines. CAP (CEVEC's Amniocyte Production) Cell Lines contain adenovirus type 5 nucleotide sequence 505-4079 including the E1 genes and the entire pIX sequence.